Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome

European Journal of Immunology

Volumn 40, Issue 1, 2010, Pages 267-278

  Dehmel, Stefan ^a   Wang, Shijun ^b   Schmidt, Claudia ^b   Kiss, Eva ^b   Loewe, Robert P ^a   Chilla, Silvia ^a   Schlöndorff, Detlef ^a,c   Gröne, Hermann Josef ^b   Luckow, Bruno ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative macrophage activation; Chemokine (C C motif) receptor 5; Knockout mice; Renal transplantation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ARGINASE 1; CHEMOKINE RECEPTOR CCR5; CHITINASE; CHITINASE 3 LIKE RESISTIN LIKE ALPHA; CREATININE; MANNOSE RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL INFILTRATION; GRAFT RECIPIENT; HISTOPATHOLOGY; IMMUNE RESPONSE; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; TH1 CELL; UPREGULATION; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL POLARITY; CYTOLOGY; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; IMMUNOLOGY; KIDNEY; KIDNEY TRANSPLANTATION; MOUSE MUTANT; PHYSIOLOGY; TIME; TREATMENT OUTCOME;

ANIMALS; CELL POLARITY; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CCR5; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 74249121961     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939652     Document Type: Article

References (52)

1. Rot, A. and von Andrian, U. H., Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 2004. 22: 891-928.
2. Luster, A. D., Alon, R. and von Andrian, U. H., Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 2005. 6: 1182-1190.
3. Nelson, P. J. and Krensky, A. M., Chemokines, chemokine receptors, and allograft rejection. Immunity 2001. 14: 377-386.
4. Tan, J. and Zhou, G., Chemokine receptors and transplantation. Cell. Mol. Immunol. 2005. 2: 343-349.
5. Viola, A. and Luster, A. D., Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 2008. 48: 171-197.
6. Blanpain, C., Libert, F., Vassart, G. and Parmentier, M., CCR5 and HIV infection. Recept. Channels 2002. 8: 19-31.
7. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S. et al., Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996. 382: 722-725.
8. Fischereder, M., Luckow, B., Hocher, B., Wü thrich, R. P., Rothenpieler, U., Schneeberger, H., Panzer, U. et al., CC chemokine receptor 5 and renal-transplant survival. Lancet 2001. 357: 1758-1761.
9. Zhou, Y. H., Kurihara, T., Ryseck, R. P., Yang, Y., Ryan, C., Loy, J., Warr, G. and Bravo, R., Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 1998. 160: 4018-4025.
10. Murai, M., Yoneyama, H., Ezaki, T., Suematsu, M., Terashima, Y., Harada, A., Hamada, H. et al., Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat. Immunol. 2003. 4: 154-160.
11. Kuziel, W. A., Dawson, T. C., Quinones, M., Garavito, E., Chenaux, G., Ahuja, S. S., Reddick, R. L. and Maeda, N., CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 2003. 167: 25-32.
12. Luckow, B., Joergensen, J., Chilla, S., Li, J. P., Henger, A., Kiss, E., Wieczorek, G. et al., Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice. Eur. J. Immunol. 2004. 34: 2568-2578.
13. Gao, W., Faia, K. L., Csizmadia, V., Smiley, S. T., Soler, D., King, J. A., Danoff, T. M. and Hancock, W. W., Beneficial effects of targeting ccr5 in allograft recipients. Transplantation 2001. 72: 1199-1205.
14. Abdi, R., Smith, R. N., Makhlouf, L., Najafian, N., Luster, A. D., Auchincloss, H., Jr., and Sayegh, M. H., The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 2002. 51: 2489-2495.
15. Schrö ppel, B., Zhang, N., Chen, P., Zang, W., Chen, D., Hudkins, K. L., Kuziel, W. A. et al., Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways. J. Am. Soc. Nephrol. 2004. 15: 1853-1861.
16. Amano, H., Bickerstaff, A., Orosz, C. G., Novick, A. C., Toma, H. and Fairchild, R. L., Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts. J. Immunol. 2005. 174: 6499-6508.
17. -/-) recipients. Am. J. Transplant. 2008. 8: 557-566.
18. Nozaki, T., Rosenblum, J. M., Schenk, A. D., Ishii, D. and Fairchild, R. L., CCR5 Is Required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts. Am. J. Transplant. 2009. 9: 2251-2261.
19. Tantravahi, J., Womer, K. L. and Kaplan, B., Why hasn't eliminating acute rejection improved graft survival? Annu. Rev. Med. 2007. 58: 369-385.
20. Cornell, L. D., Smith, R. N. and Colvin, R. B., Kidney transplantation: mechanisms of rejection and acceptance. Annu. Rev. Pathol. 2008. 3: 189-220.
21. Russell, P. S., Chase, C. M., Colvin, R. B. and Plate, J. M., Induced immune destruction of long-surviving, H-2 incompatible kidney transplants in mice. J. Exp. Med. 1978. 147: 1469-1486.
22. Martinez, F. O., Helming, L. and Gordon, S., Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009. 27: 451-483.
23. Mosser, D. M. and Edwards, J. P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008. 8: 958-969.
24. Martinez, F. O., Sica, A., Mantovani, A. and Locati, M., Macrophage activation and polarization. Front Biosci. 2008. 13: 453-461.
25. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000. 100: 655-669.
26. Campbell, D. J. and Ziegler, S. F., FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat. Rev. Immunol. 2007. 7: 305-310.
27. Chvatchko, Y., Hoogewerf, A. J., Meyer, A., Alouani, S., Juillard, P., Buser, R., Conquet, F. et al., A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J. Exp. Med. 2000. 191: 1755-1764.
28. Lee, I., Wang, L., Wells, A. D., Dorf, M. E., Ozkaynak, E. and Hancock, W. W., Recruitment of Foxp3+T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 2005. 201: 1037-1044.
29. Schneider, M. A., Meingassner, J. G., Lipp, M., Moore, H. D. and Rot, A., CCR7 is required for the in vivo function of CD4+CD25+regulatory T cells. J. Exp. Med. 2007. 204: 735-745.
30. Pai, S. Y., Truitt, M. L. and Ho, I. C., GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. USA 2004. 101: 1993-1998.
31. Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 2003. 3: 23-35.
32. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004. 25: 677-686.
33. Schrö der, C., Pierson, R. N., III, Nguyen, B. N., Kawka, D. W., Peterson, L. B., Wu, G., Zhang, T. et al., CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates. J. Immunol. 2007. 179: 2289-2299.
34. Arenzana-Seisdedos, F. and Parmentier, M., Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands. Semin. Immunol. 2006. 18: 387-403.
35. Nozaki, T., Amano, H., Bickerstaff, A., Orosz, C. G., Novick, A. C., Tanabe, K. and Fairchild, R. L., Antibody-Mediated Rejection of Cardiac Allografts in CCR5-Deficient Recipients. J. Immunol. 2007. 179: 5238-5245.
36. Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H. H., Brown, G. D. and Gordon, S., Macrophage receptors and immune recognition. Annu. Rev. Immunol. 2005. 23: 901-944.
37. Morelli, A. E. and Thomson, A. W., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007. 7: 610-621.
38. Fö rster, R., Davalos-Misslitz, A. C. and Rot, A., CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 2008. 8: 362-371.
39. Hume, D. A., Macrophages as APC and the dendritic cell myth. J. Immunol. 2008. 181: 5829-5835.
40. Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M. and Moser, B., CCR5 is characteristic of Th1 lymphocytes. Nature 1998. 391: 344-345.
41. Andres, P. G., Beck, P. L., Mizoguchi, E., Mizoguchi, A., Bhan, A. K., Dawson, T., Kuziel, W. A. et al., Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+lymphocyte- associated Th2-type immune response in the intestine. J. Immunol. 2000. 164: 6303-6312.
42. Wyburn, K. R., Jose, M. D., Wu, H., Atkins, R. C. and Chadban, S. J., The role of macrophages in allograft rejection. Transplantation 2005. 80: 1641-1647.
43. Gordon, S. and Taylor, P. R., Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005. 5: 953-964.
44. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K. and Suttles, J., Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 2005. 175: 342-349.
45. Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M. et al., Macrophage polarization in tumour progression. Semin. Cancer Biol. 2008. 18: 349-355.
46. Zhang, Z., Schlachta, C., Duff, J., Stiller, C., Grant, D. and Zhong, R., Improved techniques for kidney transplantation in mice. Microsurgery 1995. 16: 103-109.
47. Kiss, E., Adams, J., Grö ne, H. J. and Wagner, J., Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. Transplantation 2003. 76: 480-489.
48. Adams, J., Kiss, E., Arroyo, A. B., Bonrouhi, M., Sun, Q., Li, Z., Gretz, N. et al., 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am. J. Pathol. 2005. 167: 285-298.
49. Ward, J. M., Yoon, M., Anver, M. R., Haines, D. C., Kudo, G., Gonzalez, F. J. and Kimura, S., Hyalinosis and Ym1/Ym2 gene expression in the stomach and respiratory tract of 129S4/SvJae and wild-type and CYP1A2-null B6, 129 mice. Am. J. Pathol. 2001. 158: 323-332.
50. Pfaffl, M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001. 29: e45.
51. Hö pken, U. E., Droese, J., Li, J. P., Joergensen, J., Breitfeld, D., Zerwes, H. G. and Lipp, M., The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses. Eur. J. Immunol. 2004. 34: 461-470.
52. Gillies, S. D., Morrison, S. L., Oi, V. T. and Tonegawa, S., A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 1983. 33: 717-728.